INSTITUT CURIE;ONXEO;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
发明人:
JIAN-SHENG SUN,MARIE DUTREIX,MARIA QUANZ
申请号：
US16458214
公开号：
US20190314511A1
申请日:
2019.07.01
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to an optimized in vivo delivery system with endosomolytic agents for nucleic acid of therapeutic interest conjugated to molecules facilitating endocytosis, in particular for use in the treatment of cancer.
